Skip to main content

Salaries and Expenses

Schedules

TAFS: 075-0600 /X - Salaries and Expenses

Iterations:
Adjustment authority: Yes
Reporting categories: No
Line #SplitDescriptionAmountFootnotes
1000DE1Discretionary Estimated - Unob Bal: Brought forward, Oct 1 $1,823,436,942See footnotes below
Footnotes for line 1000 (DE1):

B1: This amount reflects the net of anticipated advance collections in FY 2021 for FY 2022 that would be available under a continuing resolution or enactment of an appropriations for FDA (see Sheet 2).

B2: This amount reflects the net of unappropriated excess collections precluded from obligation for ADUFA ($2,058,256), AGDUFA ($2,363,711), and MDUFA ($39,912,561).

1000ME1Mandatory Estimated - Unob Bal: Brought forward, Oct 1 $1,255,769
1061Unob Bal: Antic recov of prior year unpd/pd obl $84,970,000
1724BA: Disc: Spending auth: Precluded from ob (lim) -$79,468,729See footnotes below
Footnotes for line 1724:

B3: The total on line 1724 represents a net of an increase in FY 2022 of $617,834 for MDUFA (a new total of $40,530,395 which includes $20,240,978 in unappropriated excess collections and $20,289,417 for the 1-month reserve) and $78,850,895 for PDUFA unappropriated excess collections.

1740BA: Disc: Spending auth:Antic colls, reimbs, other $175,201,525
1802BA: Mand: Spending auth: Previously unavailable $28,500
1823SEQBA: Mand: Spending auth: New\Unob bal temp reduced -$28,500
1840BA: Mand: Spending auth:Antic colls, reimbs, other $500,000
1920Total budgetary resources avail (disc. and mand.) $2,005,895,507
6011PDUFA $353,613,886
6012MDUFA $328,867,909
6013ADUFA $25,013,876
6014AGDUFA $27,552,935
6015TOBACCO $404,162,150
6016MQSA $17,242,771
6017EREA $12,203,923
6018CONTINGENCY FUND $352,571
6019COUNTER-TERRORISM $843,878
6020Oil Spill $41
6021Priority Voucher Review $7,378,700
6022GDUFA $184,338,949
6023BSUFA $44,994,087
6026Food & Drug Safety $745,172
6027FOIA $1,837,157
6028EBOLA $63,403
6029PRV-Pediatric Disease $17,914,696
6030Outsourcing Facility $470,528
6031Energy Saving Rebates $199,435
6033Food Inspection $6,673,000
6034Food Recall $1,492,000
6035Zika Activities $131,264
6036Third Party Auditors $729,236
6037MCMi $56,322
6038VQIP $5,531,681
6039Reimbursements $8,084,000
6040Opioids-IMF $7,685,774
6042Coronavirus Emergency Funding (P.L. 116-123) $5,356,893See footnotes below
Footnotes for line 6042:

A5: HHS will inform OMB in writing five business days in advance of any deviations from FDA's activities or funding in HHS's most recent Congressional spend plan provided as required in Public Law 116-123.

6043Coronavirus Response (P.L. 116-136) $48,940,843See footnotes below
Footnotes for line 6043:

A6: HHS will inform OMB in writing five business days in advance of any deviations from FDA's activities or funding in HHS's most recent Congressional spend plan provided as required in Public Law 116-136.

6044Over the Counter Monograph $46,283,502
6045Coronavirus Response (P.L.116-139) $17,685,662See footnotes below
Footnotes for line 6045:

A7: HHS will inform OMB in writing five business days in advance of any deviations from FDA's activities or funding in HHS's most recent Congressional spend plan provided as required in Public Law 116-139.

6046Coronavirus Relief Funding (P.L. 116-260) $33,623,451See footnotes below
Footnotes for line 6046:

A8: HHS will inform OMB in writing five business days in advance of any deviations from FDA's activities or funding in HHS's most recent Congressional spend plan provided as required in Public Law 116-260.

6047Seafood Safety Studies-GP Sec. 765 $100,000
6048Coronavirus ARP Act (P.L. 117-002) $395,725,812See footnotes below
Footnotes for line 6048:

A9: Funds are available for obligation five business days after an HHS approved spend plan has been submitted to OMB.

6190Total budgetary resources available $2,005,895,507See footnotes below
Footnotes for line 6190:

A1: Details on attachments are not subject to 31 USC 1517. The term "attachments" includes but is not limited to the worksheets in this excel file that accompany the SF 132 and this footnote worksheet.

A2: Pursuant to 31 USC 1553(b), not to exceed 1 percent of total appropriation for this account is apportioned for the purpose of paying legitimate obligations related to cancelled appropriations.

A3: The total amount apportioned may be increased for additional spending authority from offsetting collections received and for recoveries of prior year obligations by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available (excluding appropriations from the Medicare trust funds). The amount of such increase is to be applied to the appropriate line in the application of budgetary resources.

A4: Amounts apportioned may not equal totals on the SF 133 due to rounding up to the next dollar. Amounts will not exceed available unobligated balances in the Unified Financial Management System for allotments.

Footnotes

Footnotes provide further information about, or establish further legal requirements related to the use of, the funds in a given line or set of lines in an apportionment. If footnotes appear on lines 1920 or 6190, they apply to all the lines in the 1xxx and 6xxx sections, respectively. The following are all the footnotes associated with this file.

NumberText
A1
Details on attachments are not subject to 31 USC 1517. The term "attachments" includes but is not limited to the worksheets in this excel file that accompany the SF 132 and this footnote worksheet.
A2
Pursuant to 31 USC 1553(b), not to exceed 1 percent of total appropriation for this account is apportioned for the purpose of paying legitimate obligations related to cancelled appropriations.
A3
The total amount apportioned may be increased for additional spending authority from offsetting collections received and for recoveries of prior year obligations by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available (excluding appropriations from the Medicare trust funds). The amount of such increase is to be applied to the appropriate line in the application of budgetary resources.
A4
Amounts apportioned may not equal totals on the SF 133 due to rounding up to the next dollar. Amounts will not exceed available unobligated balances in the Unified Financial Management System for allotments.
A5
HHS will inform OMB in writing five business days in advance of any deviations from FDA's activities or funding in HHS's most recent Congressional spend plan provided as required in Public Law 116-123.
A6
HHS will inform OMB in writing five business days in advance of any deviations from FDA's activities or funding in HHS's most recent Congressional spend plan provided as required in Public Law 116-136.
A7
HHS will inform OMB in writing five business days in advance of any deviations from FDA's activities or funding in HHS's most recent Congressional spend plan provided as required in Public Law 116-139.
A8
HHS will inform OMB in writing five business days in advance of any deviations from FDA's activities or funding in HHS's most recent Congressional spend plan provided as required in Public Law 116-260.
A9
Funds are available for obligation five business days after an HHS approved spend plan has been submitted to OMB.
B1
This amount reflects the net of anticipated advance collections in FY 2021 for FY 2022 that would be available under a continuing resolution or enactment of an appropriations for FDA (see Sheet 2).
B2
This amount reflects the net of unappropriated excess collections precluded from obligation for ADUFA ($2,058,256), AGDUFA ($2,363,711), and MDUFA ($39,912,561).
B3
The total on line 1724 represents a net of an increase in FY 2022 of $617,834 for MDUFA (a new total of $40,530,395 which includes $20,240,978 in unappropriated excess collections and $20,289,417 for the 1-month reserve) and $78,850,895 for PDUFA unappropriated excess collections.

Notes about this page

  • † Links to public laws are automatically generated and are not guaranteed to be accurate.